Concepedia

Judy S. Wang

JS

2

Publications

46

Citations

2

H-Index

2021

Active since

Affiliations

Sarah Cannon(Current)

Judy S. Wang is an author at Sarah Cannon specializing in cancer therapeutics, cancer research, and oncology.

Top concepts

Publications per year

2021–2023

2

Publications

2

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Richard D. Baird, Mafalda Oliveira, Eva María Ciruelos Gil et al. · Cancer Research · 2021 · 32 citations

, , +13

Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors

Anastasios Stathis, Anthony W. Tolcher, Judy S. Wang et al. · Investigational New Drugs · 2023 · 14 citations · Full text

Rows per page

1–2 of 2